2 completed, 2 unknown, 1 recruiting, 1 withdrawn. 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Guttate Psoriasis: new trials by email Literature Review of Guttate Psoriasis trials Research Report on Guttate Psoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate Psoriasis Ixekizumab - Guttate Psoriasis | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 50 | 2025-05-01 | 2025-02-10 |
| Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines Experts consensus - Psoriasis, Psoriasis Palmaris | Unknown | Centre of Evidence of the French Society of Dermatology | 30 | 2021-11-08 | 2021-12-03 | |
| Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis Psoriasis, Cardiovascular Diseases | Recruiting | Herlev and Gentofte Hospital | 1000 | 2021-09-01 | 2025-09-15 | |
| Guselkumab Immunogenetics Guselkumab - Psoriasis Guttate, Plaque Psoriasis | Phase 4 | Completed | University of California, San Francisco | 17 | 2021-03-01 | 2026-06-23 |
| Characterization of Cutaneous Microbiota in the Psoriasis Pathogenesis Psoriasis | Completed | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 24 | 2016-10-13 | 2018-03-23 | |
| The Effect of Algae Dunaliella Bardawil on Psoriasis (2) Alga Dunaliella Bardawil, Placebo - Psoriasis | Phase 3 | Withdrawn | Sheba Medical Center | 2010-01-01 | 2013-01-24 |
Psoriasis (4) · Cardiovascular Diseases (1) · Heart Diseases (1) · Heart Failure (1) · Heart Failure, Diastolic (1) · Heart Failure, Systolic (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Stroke (1) · Ventricular Dysfunction, Left (1)
Skin Diseases (6) · Skin Diseases, Papulosquamous (6) · Skin and Connective Tissue Diseases (6) · Psoriasis (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Infarction (1) · Ischemia (1) · Necrosis (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Vascular Diseases (1) · Ventricular Dysfunction (1)
guselkumab (1) · ixekizumab (1)
Centre of Evidence of the French Society of Dermatology (1) · Herlev and Gentofte Hospital (1) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Sheba Medical Center (1) · University of California, San Francisco (1)
Denmark (1) · France (1) · Israel (1) · United States (1)
Claus Zachariae, MD, DMSc (1) · Felix Pavlotsky,, MD (1) · Gunnar Gislason, MD, PhD (1) · Lone Skov, MD, PhD, DMSc (1) · Wilson Liao, MD (1)